StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) operating KPIs

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)

Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%

Cvs Health peer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues ($M)

Quarterly figures from Cvs Health's filings and investor materials

QuarterlyAnnual
Latest, Q3 2026
51,429
Period ended Sep 30, 2026
Change on a year earlier
+1.4%
50,711 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPeer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues ($M)Year on yearSource
Q3 2026Sep 30, 202651,429+1.4%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q2 2026Jun 30, 202650,474+1.4%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q1 2026Mar 31, 202650,181+2.6%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q4 2025Dec 31, 202549,747+9.5%Elevance Health, Inc. SEC 10-K (XBRL) ↗
Q3 2025Sep 30, 202550,711+12.4%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q2 2025Jun 30, 202549,776+13.4%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q1 2025Mar 31, 202548,891+14.8%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q4 2024Dec 31, 202445,442+6.6%Elevance Health, Inc. SEC 10-K (XBRL) ↗
Q3 2024Sep 30, 202445,106+5.3%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q2 2024Jun 30, 202443,886+0.5%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q1 2024Mar 31, 202442,577+1.0%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q4 2023Dec 31, 202342,647+6.8%Elevance Health, Inc. SEC 10-K (XBRL) ↗
Q3 2023Sep 30, 202342,849+7.3%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q2 2023Jun 30, 202343,672+13.0%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q1 2023Mar 31, 202342,172+10.7%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
Q4 2022Dec 31, 202239,929+9.2%Elevance Health, Inc. SEC 10-K (XBRL) ↗

Breakdown

What makes up peer benchmark — elevance health (elv / carelon, through q3 2026): total revenues

Cite this data

StockData. (2026). Cvs Health Peer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer_elv_revenue

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.